Around World Online Pharmacy

   Search drugs:
buy drugs without prescription
MAIN
FAQ
CONTACTS






Buy CATAPRES online:

Drugs groupShort description
Generic CATAPRES (Clonidine)


Catapres (Clonidine) is an alpha agonist used to treat high blood pressure. It is effective when used alone or with other high blood pressure medications.
CATAPRES (Generic Clonidine Hcl)


Catapres is manufactured by Intas Pharmaceuticals Limited, India.This medication is used alone or with other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Clonidine belongs to a class of drugs (central alpha agonists) that act in the brain to lower blood pressure. It works by relaxing blood vessels so blood can flow more easily.
Clonidine, CATAPRES


Clonidine is prescribed for high blood pressure.
Arkamin ( CATAPRES, Generic Clonidine )


Arkamin is Manufactured by Unisearch, India.This medication is used alone or with other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Clonidine belongs to a class of drugs (central alpha agonists) that act in the brain to lower blood pressure. It works by relaxing blood vessels so blood can flow more easily.
Used in the treatment of Tourette's syndrome, migraine headaches, ulcerative colitis, menopausal hot flashes, alcohol withdrawal, and as an aid in smoking cessation therapy.
CATAPRES ( Generic Clonidine ) - Product Origin: New Zealand


CATAPRES is indicated in the treatment of hypertension. CATAPRES may be employed alone or concomitantly with other antihypertensive agents.Dosage and Administration:TabletsIt is recommended to slowly titrate the oral dose of CATAPRES to satisfy the requirements of individual patients.InitiallyCommence on 75 mcg (Half a tablet) at night. At successive consultations (2-4 week intervals) the daily dose should be increased by half a tablet (75 mcg), until adequate blood pressure control is attained. The total daily dose is recommended to be taken once daily at night if the optimal dose is 1 tablet or less. If the total daily dose is greater than 1 tablet then dosage should be taken twice daily in evenly divided doses. Where the dosage is uneven the larger dose should be taken at night. Usually doses above 600 mcg per day do not result in a further marked drop in blood pressure.Maintenance.Most patients with mild to moderate hypertension will be controlled on a dose of 150-450 mcg daily.In more severe cases, higher doses of up to 900 mcg daily have been utilised on a 300 mcg (2 tablets), twice to three times daily dosage regimen.
CATAPRES TTS-1 ( Generic Clonidine ) - Product Origin: New Zealand


Indications:CATAPRES-TTS is indicated for the treatment of mild to moderate hypertension. It can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.Dosage and Administration:CATAPRES-TTS dosage should be titrated according to individual patient's therapeutic requirements. Commence with one CATAPRES-TTS-1 applied weekly to a freshly cleaned, hairless area of the upper outer arm or chest. A new site should be used each week when applying new patches. If after two to four weeks the desired reduction in blood pressure is not achieved, increase the weekly dosage by changing to CATAPRES-TTS-2. If this dosage is still not satisfactory after 2-4 weeks therapy then increase the weekly dosage by changing to CATAPRES-TTS-3.Most patients with mild to moderate hypertension will be controlled on one CATAPRES-TTS-3 or less. In more resistant cases where blood pressure is not satisfactorily controlled on one CATAPRES-TTS-3, it is recommended that a diuretic and/or other antihypertensive agents be added to enhance the hypotensive effect. In this way, the dose of each individual drug may be reduced and side effects minimised. Higher doses of up to two CATAPRES-TTS-3 a week have been utilised.When substituting CATAPRES-TTS in patients on prior oral antihypertensive therapy, including oral CATAPRES, physicians should be aware that the antihypertensive effect of CATAPRES-TTS might not commence until 2-3 days after initial application. Therefore, gradual reduction of prior drug dosage over 5-6 days is advised.Instructions on correct application of CATAPRES-TTS are provided on a separate patient leaflet.
CATAPRES TTS-2 ( Generic Clonidine ) - Product Origin: New Zealand


Indications:CATAPRES-TTS is indicated for the treatment of mild to moderate hypertension. It can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.Dosage and Administration:CATAPRES-TTS dosage should be titrated according to individual patient's therapeutic requirements. Commence with one CATAPRES-TTS-1 applied weekly to a freshly cleaned, hairless area of the upper outer arm or chest. A new site should be used each week when applying new patches. If after two to four weeks the desired reduction in blood pressure is not achieved, increase the weekly dosage by changing to CATAPRES-TTS-2. If this dosage is still not satisfactory after 2-4 weeks therapy then increase the weekly dosage by changing to CATAPRES-TTS-3.Most patients with mild to moderate hypertension will be controlled on one CATAPRES-TTS-3 or less. In more resistant cases where blood pressure is not satisfactorily controlled on one CATAPRES-TTS-3, it is recommended that a diuretic and/or other antihypertensive agents be added to enhance the hypotensive effect. In this way, the dose of each individual drug may be reduced and side effects minimised. Higher doses of up to two CATAPRES-TTS-3 a week have been utilised.When substituting CATAPRES-TTS in patients on prior oral antihypertensive therapy, including oral CATAPRES, physicians should be aware that the antihypertensive effect of CATAPRES-TTS might not commence until 2-3 days after initial application. Therefore, gradual reduction of prior drug dosage over 5-6 days is advised.Instructions on correct application of CATAPRES-TTS are provided on a separate patient leaflet.
CATAPRES TTS-3 ( Generic Clonidine ) - Product Origin: New Zealand


Indications:CATAPRES-TTS is indicated for the treatment of mild to moderate hypertension. It can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.Dosage and Administration:CATAPRES-TTS dosage should be titrated according to individual patient's therapeutic requirements. Commence with one CATAPRES-TTS-1 applied weekly to a freshly cleaned, hairless area of the upper outer arm or chest. A new site should be used each week when applying new patches. If after two to four weeks the desired reduction in blood pressure is not achieved, increase the weekly dosage by changing to CATAPRES-TTS-2. If this dosage is still not satisfactory after 2-4 weeks therapy then increase the weekly dosage by changing to CATAPRES-TTS-3.Most patients with mild to moderate hypertension will be controlled on one CATAPRES-TTS-3 or less. In more resistant cases where blood pressure is not satisfactorily controlled on one CATAPRES-TTS-3, it is recommended that a diuretic and/or other antihypertensive agents be added to enhance the hypotensive effect. In this way, the dose of each individual drug may be reduced and side effects minimised. Higher doses of up to two CATAPRES-TTS-3 a week have been utilised.When substituting CATAPRES-TTS in patients on prior oral antihypertensive therapy, including oral CATAPRES, physicians should be aware that the antihypertensive effect of CATAPRES-TTS might not commence until 2-3 days after initial application. Therefore, gradual reduction of prior drug dosage over 5-6 days is advised.Instructions on correct application of CATAPRES-TTS are provided on a separate patient leaflet.



Bookmark This Site
Bookmark This Page

Must popular
drugs online:


Online Pharmacy Home |  Buy Drugs Online FAQ |  Contact Online Pharmacy


Copyright © Pharmacy.Around-World.biz 2003-2012